Beginning Cash: The amount of cash reported by the company on its previous statement.
Structure Therapeutics Inc. Sponsored ADR (GPCR) had Beginning Cash of $169.51M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$33.00M |
|
-- |
|
-- |
|
$-23.99M |
|
$23.99M |
|
$9.19M |
|
$33.17M |
|
$33.17M |
|
$33.00M |
|
$33.00M |
|
$33.00M |
|
$33.00M |
|
$23.99M |
|
$37.57M |
|
59.20M |
|
59.20M |
|
$0.62 |
|
$0.62 |
|
| Balance Sheet Financials | |
$1.57B |
|
$6.65M |
|
$13.62M |
|
$1.58B |
|
$63.28M |
|
-- |
|
$4.26M |
|
$67.54M |
|
$1.52B |
|
$1.52B |
|
$1.52B |
|
70.84M |
|
| Cash Flow Statement Financials | |
$-222.20M |
|
$89.80M |
|
$762.52M |
|
|
Beginning Cash |
$169.51M |
$799.62M |
|
$630.11M |
|
$28.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-225.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2.18% |
|
2.18% |
|
2.08% |
|
2.18% |
|
$21.41 |
|
$-3.81 |
|
$-3.75 |
|